Pages that link to "Q22009048"
Jump to navigation
Jump to search
The following pages link to Covalent and noncovalent modifiers of the p53 protein (Q22009048):
Displaying 50 items.
- tumor protein p53 (Q283350) (← links)
- Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases (Q24298420) (← links)
- Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53 (Q24551160) (← links)
- Functional interaction of p53 and BLM DNA helicase in apoptosis (Q28201136) (← links)
- The processing of Holliday junctions by BLM and WRN helicases is regulated by p53 (Q28206425) (← links)
- Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction (Q28208109) (← links)
- DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer (Q28253026) (← links)
- ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage (Q28364113) (← links)
- Activation and activities of the p53 tumour suppressor protein (Q28366563) (← links)
- Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer. (Q30374671) (← links)
- The cellular response to p53: the decision between life and death (Q33771774) (← links)
- Regulation of p53 stability (Q33807793) (← links)
- Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. (Q33807844) (← links)
- Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation. (Q33963311) (← links)
- Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells (Q33964769) (← links)
- Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress (Q33997846) (← links)
- Strategies for manipulating the p53 pathway in the treatment of human cancer. (Q34076012) (← links)
- Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells (Q34324710) (← links)
- Inflammation, carcinogenesis and cancer (Q34372773) (← links)
- P53-responsive genes and the potential for cancer diagnostics and therapeutics development (Q34423327) (← links)
- Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA (Q34490497) (← links)
- A single-molecule characterization of p53 search on DNA (Q34490695) (← links)
- A role for p53 in the frequency and mechanism of mutation (Q34572898) (← links)
- A role for p53 in base excision repair. (Q34582602) (← links)
- Activation of the p53 tumor suppressor protein (Q34605518) (← links)
- Does p53 affect organismal aging? (Q34736706) (← links)
- Methods for screening tumors for p53 status and therapeutic exploitation. (Q35142162) (← links)
- Dancing on DNA: kinetic aspects of search processes on DNA (Q36110835) (← links)
- The functional domains in p53 family proteins exhibit both common and distinct properties (Q36423942) (← links)
- Transcriptional regulation by p53: one protein, many possibilities (Q36436698) (← links)
- SIRT1 alleviates senescence of degenerative human intervertebral disc cartilage endo-plate cells via the p53/p21 pathway (Q36650996) (← links)
- Mutant p53: an oncogenic transcription factor (Q36777355) (← links)
- Identification of p53 regulators by genome-wide functional analysis (Q37073614) (← links)
- Intrinsically disordered regions as affinity tuners in protein-DNA interactions (Q37932415) (← links)
- Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination (Q38298688) (← links)
- DNA Structure and Polymerase Fidelity: A New Role for A-DNA. (Q38316929) (← links)
- Recognition of DNA modified by antitumor cisplatin by “latent” and “active” protein p53 (Q38355560) (← links)
- New ELISA technique for analysis of p53 protein/DNA binding properties. (Q38363788) (← links)
- KSHV latent protein LANA2 inhibits sumo2 modification of p53. (Q38917974) (← links)
- Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease? (Q38934098) (← links)
- Activation of p53 protein by telomeric (TTAGGG)n repeats (Q39516161) (← links)
- Gambogic acid‐induced degradation of mutant p53 is mediated by proteasome and related to CHIP (Q39602480) (← links)
- Inhibition of p53 tumor suppressor by viral interferon regulatory factor (Q39606488) (← links)
- Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein (Q39675422) (← links)
- Role of tumor suppressor p53 domains in selective binding to supercoiled DNA. (Q39687338) (← links)
- Replication of damaged DNA in vitro is blocked by p53. (Q39792211) (← links)
- The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12. (Q39842398) (← links)
- Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis (Q40442787) (← links)
- A three-dimensional skin equivalent reflecting some aspects of in vivo aged skin. (Q40462785) (← links)
- Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein (Q40589165) (← links)